SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : UTHR-a Promising Biotech in the works here?
UTHR 438.62-1.5%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kendall harmon who wrote ()8/17/1999 4:34:00 PM
From: kendall harmon   of 66
 
UTHR--money manager's comments

Gerald Frey, Manager, Delaware Aggressive Growth Fund

Are there any aggressive short-term plays that you are investing in right now?
Yes. United Therapeutics (UTHR) is one that could be interesting in the short term. It's a smaller biotech pharmaceutical company. They have a number of products that are in phase 3 trials. Some of the trials that they conducted in Europe look as if they will probably be very successful here in the United States. And these products address large and unmet markets in the U.S. Their management team comes from Glaxo Wellcome (GLX) and is very experienced. So I think there is strong potential there. The company is presently in the investment mode and will not be profitable until 2001.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext